ABBVIE INC. vs. NextCure, Inc. Common Stock
ABBVIE INC. and NextCure, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | NXTC | |
|---|---|---|
| Market Cap | $430.82 billion | $21.36 million |
| Revenue (TTM) | — | — |
| Net Income (TTM) | — | $-54,664,000 |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | NXTC | |
|---|---|---|
| Price / Book | — | 0.80 |
ABBV and NXTC split the valuation factors evenly.
Profitability
| ABBV | NXTC | |
|---|---|---|
| Return on Equity | — | -204.61% |
ABBV and NXTC split the profitability factors evenly.
Dividend
| ABBV | NXTC | |
|---|---|---|
| Dividend Yield | 2.81% | — |
ABBV and NXTC split the dividend factors evenly.
Risk & Sentiment
| ABBV | NXTC | |
|---|---|---|
| Short Interest | 0.85% | 0.05% |
NXTC leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, NXTC overview, NXTC financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.